Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Stepwise bladder carcinogenesis reveals transcriptional reprogramming involving MMP1 and COL7A1

Created on 10 Sep 2026

Authors

Nagashima, Y., Elbadawy, M., Naito, Y., Abugomaa, A., Tsunedomi, R., Kaneda, M., Usui, T., Sasaki, K.

Abstract

Bladder cancer develops through multistep molecular alterations, yet the events underlying tumor initiation and progression remain poorly understood. Here, we reconstructed stepwise bladder carcinogenesis using canine bladder organoids combined with chemical carcinogenesis and serial xenotransplantation. Carcinogen-exposed normal organoids generated benign tumors that subsequently progressed to invasive carcinomas. Despite a low tumor mutational burden and limited acquisition of cancer-associated mutations, malignant progression was accompanied by extensive transcriptional reprogramming, including enrichment of epithelial-to-mesenchymal transition programs. COL7A1 and MMP1 were progressively upregulated during progression, and knockdown of either gene suppressed organoid proliferation and invasion. These functional dependencies were reproduced in independently established spontaneous canine bladder cancer organoids, where silencing of either gene also reduced xenograft growth and mitosis-related gene programs. MMP1 knockdown decreased COL7A1 expression, suggesting a potential regulatory relationship. MMP1 was also elevated in basal/squamous human bladder cancers, and its depletion suppressed human bladder cancer cell proliferation. These findings identify transcriptional reprogramming and MMP1/COL7A1 dependencies as prominent features of malignant progression.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 10 Sep 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement